Guidewire, Catheter Draft Guidance Docs Address Coating Risks
Executive Summary
US FDA issued two draft guidelines June 14 addressing labeling and performance testing for guidewires and other interventional vascular devices. The draft recommendations address risks that have been identified in recent years resulting from the separation of coating material from the devices during deployment.
You may also be interested in...
US FDA Issues Labeling Guidelines For Chemically Coated Devices
After discovering a correlation between certain chemically coated devices and serious adverse events, the agency has issued a couple of final guidance documents, including a labeling guidance to increase public awareness of the risks. The coating is meant to help physicians more easily slide devices – such as catheters and guidewires – into patients, but in some cases they’ve been associated with obstruction of blood vessels, stroke and death.
FDA Warns Of Coating Separation Risks For Intravascular Devices
The agency's alert, which is not tied to any specific manufacturer or product, states that peeling coatings have led to 11 recalls since 2010 and 500 adverse event reports since 2014.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.